LONDON, May 13 - Genomic companies could be forgiven for asking whether patenting really is the best way to protect their IP. The costs of obtaining a biotech patent are large, the prosecution period is often lengthy--not to say uncertain-and, following grant, the lifetime of a patent may only be a decade or so.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.